PaxMedica To Provide Immediate PAX-101 IV Suramin Access
23 Apr 2024 //
GLOBENEWSWIRE
PaxMedica Receives Emergency IV Suramin Request from African Health Ministry
16 Apr 2024 //
GLOBENEWSWIRE
SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy
10 Jan 2022 //
CLINICALTRIALSARENA
PaxMedica Plans to Initiate Phase 1B Study for PAX-101 in COVID-19 Syndrome
07 Jan 2022 //
PRNEWSWIRE
IV suramin may be a promising autism treatment, shows Phase II study
29 Oct 2021 //
EUROPEANPHARMACEUTICALREVIEW